Role of abbreviated MRI protocol for screening of HCC in HCV related cirrhotic patients prior to direct-acting antiviral treatment
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2090-4762
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Role of abbreviated MRI protocol for screening of HCC in HCV related cirrhotic patients prior to direct-acting antiviral treatment ; volume:51 ; number:1 ; day:16 ; month:6 ; year:2020 ; pages:1-7 ; date:12.2020
The Egyptian Journal of Radiology and Nuclear Medicine ; 51, Heft 1 (16.6.2020), 1-7, 12.2020
- Urheber
-
Ahmed, Nora Nabil Abdou
Gaafary, Sahar Mohamed El
Elia, Remon Zaher
Abdulhafiz, Essam Mohamed
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s43055-020-00199-x
- URN
-
urn:nbn:de:101:1-2020081320483877727424
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ahmed, Nora Nabil Abdou
- Gaafary, Sahar Mohamed El
- Elia, Remon Zaher
- Abdulhafiz, Essam Mohamed
- SpringerLink (Online service)
Ähnliche Objekte (12)
Effect of direct-acting antiviral drugs on portal circulation hemodynamics in cirrhotic patients infected with HCV
HCC screening: assessment of an abbreviated non-contrast MRI protocol
In silico analysis excavates potential biomarkers by constructing miRNA-mRNA networks between non-cirrhotic HCC and cirrhotic HCC
Evaluation of fibrosis in cirrhotic elderly patients with HCC
Peripheral immune signatures associated with the risk of hepatocarcinogenesis in cirrhotic Egyptian HCV patients before and after treatment with direct-acting antivirals
Cryptogenic non-cirrhotic HCC: Clinical, prognostic and immunologic aspects of an emerging HCC etiology
Correction: Peripheral immune signatures associated with the risk of hepatocarcinogenesis in cirrhotic Egyptian HCV patients before and after treatment with direct-acting antivirals
Preoperative Liver Function Guiding HCC Resection in Normal and Cirrhotic Liver
Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era
Serum autotaxin levels in responders to HCV treatment by direct-acting antivirals
CD8+ T cell responses during HCV infection and HCC
Regional Ischemic Preconditioning Has Clinical Value in Cirrhotic HCC Through MAPK Pathways
Effect of direct-acting antiviral drugs on portal circulation hemodynamics in cirrhotic patients infected with HCV
HCC screening: assessment of an abbreviated non-contrast MRI protocol
In silico analysis excavates potential biomarkers by constructing miRNA-mRNA networks between non-cirrhotic HCC and cirrhotic HCC
Evaluation of fibrosis in cirrhotic elderly patients with HCC
Peripheral immune signatures associated with the risk of hepatocarcinogenesis in cirrhotic Egyptian HCV patients before and after treatment with direct-acting antivirals
Cryptogenic non-cirrhotic HCC: Clinical, prognostic and immunologic aspects of an emerging HCC etiology
Correction: Peripheral immune signatures associated with the risk of hepatocarcinogenesis in cirrhotic Egyptian HCV patients before and after treatment with direct-acting antivirals
Preoperative Liver Function Guiding HCC Resection in Normal and Cirrhotic Liver
Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era
Serum autotaxin levels in responders to HCV treatment by direct-acting antivirals
CD8+ T cell responses during HCV infection and HCC
Regional Ischemic Preconditioning Has Clinical Value in Cirrhotic HCC Through MAPK Pathways
Effect of direct-acting antiviral drugs on portal circulation hemodynamics in cirrhotic patients infected with HCV
HCC screening: assessment of an abbreviated non-contrast MRI protocol
In silico analysis excavates potential biomarkers by constructing miRNA-mRNA networks between non-cirrhotic HCC and cirrhotic HCC
Evaluation of fibrosis in cirrhotic elderly patients with HCC
Peripheral immune signatures associated with the risk of hepatocarcinogenesis in cirrhotic Egyptian HCV patients before and after treatment with direct-acting antivirals
Cryptogenic non-cirrhotic HCC: Clinical, prognostic and immunologic aspects of an emerging HCC etiology
Correction: Peripheral immune signatures associated with the risk of hepatocarcinogenesis in cirrhotic Egyptian HCV patients before and after treatment with direct-acting antivirals
Preoperative Liver Function Guiding HCC Resection in Normal and Cirrhotic Liver
Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era
Serum autotaxin levels in responders to HCV treatment by direct-acting antivirals
CD8+ T cell responses during HCV infection and HCC